New Key Statistics Module, Z-Score and F-Score
NAS:UPC Key Ratios
| Market Cap $ M | 8.09 |
| Enterprise Value $ M | -4.93 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.20 |
| Price/Sales | 0.25 |
| Price/Free Cash Flow | 7.47 |
| Price/Owner Earnings | 46.25 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 32.00 |
| EPS (TTM) $ | -1.70 |
| Beneish M-Score | -3.13 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 1.33 |
| EV-to-EBITDA | 1.55 |
| PEG | -- |
| Shares Outstanding M | 3.65 |
| Net Margin (%) | -19.08 |
| Operating Margin % | -12.28 |
| Pre-tax Margin (%) | -11.92 |
| Quick Ratio | 2.43 |
| Current Ratio | 2.68 |
| ROA % (ttm) | -10.09 |
| ROE % (ttm) | -13.89 |
| ROIC % (ttm) | -22.96 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.52 |
UPC Number of Guru Trades
UPC Volume of Guru Trades
Gurus Latest Trades with NAS:UPC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:UPC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Universe Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:UPC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers